Managing remnant cholesterol: role of fenofibrate–statin therapy in reducing triglyceride-rich lipoproteins

• by Vikrama Raja, Carlos Aguiar, Nasreen Alsayed, Yogeyaa S. Chibber, Hussein ElBadawi, Michel Farnier, Kumari Pushpa, Lale Tokgözoglu, Alberto Zambon, Jean-Pascal Berrou, Michel P. Hermans

• June 4, 2026

Machine Learning Prediction Model for Dyslipidemia and Its Association With Atherothrombotic Events in 3 Independent Cohorts From South Korea, Japan, and the United Kingdom: Algorithm Development and Validation Study

• by Tae Hyeon Kim, Soeun Kim, Yerim Kim, Hayeon Lee, Seung Ha Hwang, So Young Yang, Lee Smith, André Hajek, Selin Woo, Dong Keon Yon

• May 19, 2026

Retinal Age as Disease Biomarker

Fundus-based AI screening can indicate “retinal age” of patients, as well as flag systemic disease risks, says new study

• May 27, 2026

• 3 min

Wearables May Boost T2D Mobility

Outpatient intervention combined physiotherapist counseling with wrist-worn activity monitoring.

• by Kathryn Wighton

• May 11, 2026

• 4 min